Quetiapine for the treatment of delirium

Journal of Hospital Medicine

Volumn 8, Issue 4, 2013, Pages 215-220

  Hawkins, Stefanie B ^a   Bucklin, Mason ^b   Muzyk, Andrew J ^c,d  

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c CAMPBELL UNIVERSITY   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; HALOPERIDOL; QUETIAPINE;

AGITATION; DATA SYNTHESIS; DELIRIUM; DELUSION; DISORIENTATION; DRUG EFFICACY; HALLUCINATION; HUMAN; HYPERACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDER;

ANTIPSYCHOTIC AGENTS; DELIRIUM; DIBENZOTHIAZEPINES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84876132774     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.2019     Document Type: Review

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: APA; 1994.
2. American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry. 1999;156:1-20.
3. Hipp DM, Ely EW. Pharmacological and nonpharmacological management of delirium in critically ill patients. Neurotherapeutics. 2012;9:158-175.
4. Stiefel F, Holland J. Delirium in cancer patients. Int Psychogeriatr. 1991;3:333-336.
5. Perry S. Organic mental disorders caused by HIV: update on early-diagnosis and treatment. Am J Psychiatry. 1990;147:696-710.
6. Tune LE. Post-operative delirium. Int Psychogeriatr. 1991;3:325-332.
7. Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry. 1983;140:1048-1050.
8. Seitz DP, Sudeep SG, van Zyl LT. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry. 2007;68:11-21.
9. Inouye S, Horowitz R, Tinetti M, et al. Acute confusional states in the hospitalized elderly: incidence, risk factors and complications [abstract]. Clin Res. 1989;37:524A.
10. Cole MG, Primeau FJ. Prognosis of delirium in elderly hospital patients. CMAJ. 1993;149:41-46.
11. Koizumi J, Shiraishi H, Suzuki T. Duration of delirium shortened by the correction of electrolyte imbalance. Jpn J Psychiatry Neurol. 1988;42:81-88.
12. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-141.
13. Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely EW. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care. 2005;9:R375-R381.
14. Milbrandt EB, Deppen S, Harrison PL, et al. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004;32:955-962.
15. Cook IA: Guideline Watch: Practice Guideline for the Treatment of Patients With Delirium. Arlington, VA:American Psychiatric Association, 2004. Available at: http://www.psych.org/psych_pract/treatg/pg/prac_guide.cfm. Accessed March 5, 2012.
16. Han C, Kim YK. A double-blind trial of risperdone and haloperidol for the treatment of delirium. Psychosomatics. 2004;45:297-301.
17. Skrobik YK, Bergeron N, Dumont M, Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med. 2004;30:444-449.
18. Girard TD, Pandharipande PP, Carson SS, et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med. 2010;38:428-437.
19. Tahir TA, Eeles E, Karapareddy V, et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. Psychosom Res. 2010;69:485-490.
20. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38:419-427.
21. Devlin JW, Skrobik Y, Riker RR, et al. Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Critical Care. 2011;15:R215.
22. Sipahimalani A, Masand PS. Olanzapine in the treatment of delirium. Psychosomatics. 1998;39:422-430.
23. Grover S, Kumar V, Chakrabarti S. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res. 2011;71:277-281.
24. Schwartz TL, Masand P. Treatment of delirium with quetiapine. J Clin Psychiatry. 2000;2:10-12.
25. Pae CU, Lee SJ, Lee CU, Lee C, Paik IH. A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol Clin Exp. 2004;19:125-127.
26. Maneeton B, Maneeton N, Srisurapanont M. An open-label study of quetiapine for delirium. J Med Assoc Thai. 2007;10:2158-2163.
27. Kim KY, Bader GM, Kotlyar V, Gropper, D. Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol. 2003;16:29-31.
28. Sasaki Y, Matsuyama T, Inoue S, et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry. 2003;64:1316-1321.
29. Lee KU, Won WY, Lee HK, et al. Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study. Int Clin Psychopharmacol. 2005;20:311-314.
30. Campbell N, Boustani MA, Ayub A, et al. Pharmacological management of delirium in hospitalized adults-a systematic evidence review. J Gen Intern Med. 2009;24:848-853.
31. Lacasse H, Perreault MM, Williamson DR. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother. 2006;40:1966-1973.
32. Rea RS, Battistone S, Fong JJ, Devlin JW. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007;27:588-594.
33. Cole MG, Primeau FJ, Elie LM. Delirium: prevention, treatment, and outcome studies. J Geriatr Psychiatry Neurol. 1998;11:126-137.
34. Saller CF, Salama AI. Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology. 1993;112:285-292.
35. Seroquel [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP; December 2011.
36. Harrigan EP, Miceli JJ, Anziano R, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004;24:62-69.
37. Kales HC, Valenstein M, Kim HM, et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry. 2007;164:1568-1576.
38. Gill S, Bronskill SE, Normand SL, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146:775-786.
39. Wang PS, Schneeweis S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med. 2005;353:2335-2341.
40. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225-235.
41. Elie M, Boss K, Cole MG, McCusker J, Belzile E, Ciampi A. A retrospective, exploratory, secondary analysis of the association between antipsychotic use and mortality in elderly patients with delirium. Int Psychogeriatr. 2009;21(3):588-592.
42. Walgreens Co. Price your drugs Available at: http://www.walgreens.com/pharmacy/psc/drugpricing/psc_drug_pricing.jsp. Accessed December 17, 2012.